Prelude Therapeutics Inc
PRLD
$3.96+1.28%
End of day · as of Sep 30, 2026, 2:32 AM ET
Mkt cap
$346.46M
EV/Sales
25.6
P/E ratio
N/A
FY2025 Revenue
$12.14M
EPS (TTM)
$-0.73
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-819.59%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported PRLD revenue for 2025-12-31 was $12.1M. Net income was -$99.5M. Revenue was up 73.4% from 2024-12-31 to 2025-12-31. PRLD currently screens at market cap $346.5M.
Use this PRLD research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full PRLD income, balance, and cash tables.
Prelude Therapeutics Inc (PRLD) is a biotechnology company in the Healthcare sector.
Latest cached Prelude Therapeutics Inc (PRLD) revenue for Dec 31, 2025 was $12.1M. Net income was -$99.5M. Statements: https://lician.com/financials/prld
Prelude Therapeutics Inc (PRLD) market capitalization is $346.5M on the latest cached snapshot.
Prelude Therapeutics Inc (PRLD) cached previous close $3.91; day range $3.83 – $4.00; volume 457,879. Session quote: https://lician.com/quote/prld
Prelude Therapeutics Inc (PRLD) latest cached earnings event is "PRLD earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached PRLD filing is 8-K · Sep 10, 2026. Filings: https://lician.com/sec/prld